Hematologic Malignancy
Myeloid Leukemia Associated with Down Syndrome
CI-CAN-00001252MLDSExplore in graph →
PediatricHematologic3 active trials
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001252MLDSExplore in graph →
Variants & evidence
1 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|
| GATA1 Mutation1 | |||||||
| (diagnostic) | Diagnostic | A | Supports Positive | 5 | submitted | EID8511Children with Down syndrome are at increased risk to developing Transient Abnormal Myelopoiesis (TAM) and Myeloid Leukemia associated with Down Syndrome (ML-DS). GATA1, a gene that encodes an essentia… (full text at CIViC) PMID 27069254 · Arber et al., 2016 · Open in CIViC | civic |
Data updated 11 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.